Teriflunomide slows BVL in relapsing MS: A reanalysis of the TEMSO MRI data set using SIENA

OBJECTIVE: To assess, using structural image evaluation using normalization of atrophy (SIENA), the effect of teriflunomide, a once-daily oral immunomodulator, on brain volume loss (BVL) in patients with relapsing forms of MS enrolled in the phase 3 TEMSO study. METHODS: TEMSO MR scans were analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Radue, Ernst-Wilhelm, Sprenger, Till, Gaetano, Laura, Mueller-Lenke, Nicole, Cavalier, Steve, Thangavelu, Karthinathan, Panzara, Michael A., Donaldson, Jessica E., Woodward, Fiona M., Wuerfel, Jens, Wolinsky, Jerry S., Kappos, Ludwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550381/
https://www.ncbi.nlm.nih.gov/pubmed/28828394
http://dx.doi.org/10.1212/NXI.0000000000000390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550381/
https://www.ncbi.nlm.nih.gov/pubmed/28828394
http://dx.doi.org/10.1212/NXI.0000000000000390

Ejemplares similares